Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2026-01-01 @ 10:09 AM
Study NCT ID:
NCT02662556
Status:
COMPLETED
Last Update Posted:
2017-03-15
First Post:
2016-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Multicenter, Open-Label Trial to Evaluate the Safety and Efficacy of the Sufentanil Sublingual Tablet 30 mcg in Patients With Post-Operative Pain
Sponsor:
Talphera, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03
Start Date Type:
None
Primary Completion Date:
2016-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-07
Completion Date Type:
ACTUAL
First Submit Date:
2016-01-20
First Submit QC Date:
None
Study First Post Date:
2016-01-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-11-07
Results First Submit QC Date:
None
Results First Post Date:
2017-03-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-01-25
Last Update Post Date:
2017-03-15
Last Update Post Date Type:
ACTUAL